AOL AIM To Shut Down; 4 Apps That Could Replace It

After 20 years, Verizon Communications Inc. VZ 0.42% is officially shutting down AOL Instant Messenger. AIM was one of the first online messaging services to catch on in mainstream America. At its peak, AIM had more than 18 million simultaneous users, and the ability to communicate instantly made AIM a huge hit on Wall Street.

Online Brokerage Shares Dip On Old News

A new Financial Times article Friday reminded investors of an ongoing investigation in Massachusetts related to a practice known as brokerage payment for order flow. The article suggests broker order routing revenue may be at risk, sending shares of online brokerage stocks tumbling.

What A Week For MannKind

MannKind Corporation (NASDAQ: MNKD) investors haven’t had much to cheer about lately, with the stock down more than 80 percent in the past three years. However, this week provided investors with a bit of optimism and traders with a huge opportunity for profits.

Acadia’s FDA Breakthrough Designation For Pimavanserin Draws Mixed Response

ACADIA Pharmaceuticals Inc. ACAD 1.92% stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough Designation to the company’s dementia-related psychosis drug candidate Pimavanserin. However, the stock quickly reversed direction as the market digested the news and was trading at under $39 in the early afternoon session as the market digests the news.

FedEx, UPS Shrug Off Amazon Challenge…For Now

Shares of FedEx Corporation FDX 0.33% and United Parcel Service Inc. UPS 1.35% are holding up relatively well on Thursday after Bloomberg reported Amazon.com, Inc. AMZN 0.33% is testing its own delivery program called Seller Flex. Amazon has a long track record of disrupting entire businesses and crushing its competition, but shares of UPS and FedEx were both down less than 2 percent on Thursday in…

Collegium Rallies On ‘Value-Based Contract’ With Cigna; Here’s What It Means

Collegium Pharmaceuticals Inc COLL 10.86% shares jumped more than 13 percent on Thursday after health insurance giant CIGNA Corporation CI 0.23% announced it will be discontinuing coverage of Purdue Pharma’s popular opioid painkiller OxyContin. Citing safety concerns about opioid abuse and addiction, CIGNA has opted instead to sign a “value-based contract” with Collegium for its abuse-deterrent oxycodone equivalent drug Xtampza ER.